Transrectal Prostate Biopsy

1. What is a Transrectal Prostate Biopsy?
A transrectal prostate biopsy is a diagnostic procedure in which small tissue samples are obtained from the prostate using a biopsy needle introduced through the rectum, usually under transrectal ultrasound guidance.

2. Why is a prostate biopsy recommended?
A biopsy may be recommended when there is an abnormal PSA level, suspicious digital rectal examination, or an abnormal finding on prostate MRI. It provides tissue confirmation when prostate cancer is suspected.

3. How is the biopsy performed?
The patient is positioned for the procedure and local anesthesia is usually administered. An ultrasound probe is inserted into the rectum to visualize the prostate, after which a biopsy needle is used to collect multiple tissue samples.

4. Is MRI used before a prostate biopsy?
Multiparametric MRI (mpMRI) is increasingly used before biopsy when appropriate. It can identify suspicious areas and allow targeted sampling, which may be combined with systematic biopsy depending on the clinical situation.

5. How many tissue samples are taken?
The number varies according to the biopsy technique and prostate findings. Systematic biopsies commonly involve multiple cores taken from different regions, while additional targeted cores may be obtained from MRI-suspicious areas.

6. How long does the procedure take?
The biopsy itself commonly takes around 15–30 minutes, although preparation and post-procedure observation may make the total visit longer. Most patients can return home the same day if there are no complications.

7. What happens after the biopsy?
The tissue samples are sent to a pathology laboratory for microscopic examination. The pathology report may determine whether cancer is present and, if so, provide information such as the Gleason Grade Group, which helps guide further treatment planning.

8. What are the risks and side effects?
Temporary blood in the urine, semen, or stool can occur. Other possible complications include discomfort, urinary difficulty, bleeding, and infection. Fever, chills, severe illness, or difficulty passing urine after biopsy requires prompt medical assessment because serious infection can occasionally occur.

9. Why consider India for prostate biopsy?
India has experienced urologists, modern imaging facilities, advanced pathology laboratories, and centres offering MRI-guided or MRI-targeted prostate biopsy services at comparatively competitive costs.

10. How can Medavelle help?
Medavelle can coordinate medical-record and imaging review, identify an appropriate urologist and hospital, obtain an indicative diagnostic plan and quotation, and assist with hospital and travel coordination for international patients.